Ammarin Thakkinstian1, Catherine D'Este, John Attia. 1. Clinical Epidemiology Unit, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Rama 6 Rd, 10400, Bangkok, Thailand. raatk@mahidol.ac.th
Abstract
INTRODUCTION: Although many studies have addressed the relationship between multiple individual polymorphisms in the vitamin D receptor (VDR) gene and bone health, few have analyzed this data in terms of haplotypes. We performed a meta-analysis of studies with data on the BsmI, ApaI, and TaqI polymorphisms in order to (a) estimate haplotype frequencies, (b) determine linkage disequilibrium (LD), and (c) estimate the magnitude of the association between haplotypes and osteoporosis/bone mineral density (BMD). METHODS: Haplotypes were inferred using the expectation-maximization algorithm (EM); log-linear models were used to determine association with osteoporosis; and regression analysis with variance components was used to determine association with BMD. RESULTS: Our results indicate that the most common haplotype for the VDR gene, regardless of ethnicity, is baT, followed by BAt and bAT in Caucasians, and bAT and BaT in Asians. This indicates strong LD between the BsmI and TaqI polymorphisms. We demonstrate a gain in power when considering the haplotypes rather than the individual polymorphisms separately, i.e., although BsmI, ApaI, and TaqI were not significantly associated with osteoporosis on their own, the haplotypes Bat and BAt were significantly associated, with an OR of approximately 4. CONCLUSION: We have applied haplotype analysis to the VDR polymorphisms and bone measures. We also highlight a number of methodologic issues, including linkage disequilibrium, the robustness of the EM algorithm in this context, and the potential for exploring effect modification.
INTRODUCTION: Although many studies have addressed the relationship between multiple individual polymorphisms in the vitamin D receptor (VDR) gene and bone health, few have analyzed this data in terms of haplotypes. We performed a meta-analysis of studies with data on the BsmI, ApaI, and TaqI polymorphisms in order to (a) estimate haplotype frequencies, (b) determine linkage disequilibrium (LD), and (c) estimate the magnitude of the association between haplotypes and osteoporosis/bone mineral density (BMD). METHODS: Haplotypes were inferred using the expectation-maximization algorithm (EM); log-linear models were used to determine association with osteoporosis; and regression analysis with variance components was used to determine association with BMD. RESULTS: Our results indicate that the most common haplotype for the VDR gene, regardless of ethnicity, is baT, followed by BAt and bAT in Caucasians, and bAT and BaT in Asians. This indicates strong LD between the BsmI and TaqI polymorphisms. We demonstrate a gain in power when considering the haplotypes rather than the individual polymorphisms separately, i.e., although BsmI, ApaI, and TaqI were not significantly associated with osteoporosis on their own, the haplotypes Bat and BAt were significantly associated, with an OR of approximately 4. CONCLUSION: We have applied haplotype analysis to the VDR polymorphisms and bone measures. We also highlight a number of methodologic issues, including linkage disequilibrium, the robustness of the EM algorithm in this context, and the potential for exploring effect modification.
Authors: A G Uitterlinden; A E Weel; H Burger; Y Fang; C M van Duijn; A Hofman; J P van Leeuwen; H A Pols Journal: J Bone Miner Res Date: 2001-02 Impact factor: 6.741
Authors: Richard M Single; Diogo Meyer; Jill A Hollenbach; Mark P Nelson; Janelle A Noble; Henry A Erlich; Glenys Thomson Journal: Genet Epidemiol Date: 2002-02 Impact factor: 2.135
Authors: P P Bitti; B S Murgia; A Ticca; R Ferrai; L Musu; M L Piras; E Puledda; S Campo; S Durando; C Montomoli; D G Clayton; A P Mander; L Bernardinelli Journal: Genet Epidemiol Date: 2001-02 Impact factor: 2.135
Authors: E M Lau; R P Young; S C Ho; J Woo; J L Kwok; Z Birjandi; G N Thomas; A Sham; J A Critchley Journal: Osteoporos Int Date: 1999 Impact factor: 4.507
Authors: E Boschitsch; E K Suk; W R Mayr; T Lang; W M Schwartz; S Panzer; B Ewald; S Eun-Kyun; M W Richard; L Thomas; S W Dieter; P Simon Journal: Maturitas Date: 1996-05 Impact factor: 4.342
Authors: A Tokita; H Matsumoto; N A Morrison; T Tawa; Y Miura; K Fukamauchi; N Mitsuhashi; M Irimoto; S Yamamori; M Miura; T Watanabe; Y Kuwabara; K Yabuta; J A Eisman Journal: J Bone Miner Res Date: 1996-07 Impact factor: 6.741
Authors: J M Staton; M S Sayer; G J Hankey; J Attia; A Thakkinstian; Q Yi; V J Cole; R Baker; J W Eikelboom Journal: J Neurol Neurosurg Psychiatry Date: 2006-09 Impact factor: 10.154
Authors: Zudin Puthucheary; James R A Skipworth; Jai Rawal; Mike Loosemore; Ken Van Someren; Hugh E Montgomery Journal: Sports Med Date: 2011-10-01 Impact factor: 11.136
Authors: Tess V Clendenen; Alan A Arslan; Karen L Koenig; Kerstin Enquist; Isaac Wirgin; Asa Agren; Annekatrin Lukanova; Hubert Sjodin; Anne Zeleniuch-Jacquotte; Roy E Shore; Göran Hallmans; Paolo Toniolo; Eva Lundin Journal: Cancer Lett Date: 2008-02-18 Impact factor: 8.679
Authors: C Chatzipapas; S Boikos; G I Drosos; K Kazakos; G Tripsianis; A Serbis; S Stergiopoulos; C Tilkeridis; D-A Verettas; C A Stratakis Journal: Horm Metab Res Date: 2009-04-23 Impact factor: 2.936
Authors: Jana Flügge; Solveigh Krusekopf; Mark Goldammer; Elena Osswald; Werner Terhalle; Uwe Malzahn; Ivar Roots Journal: Eur J Clin Pharmacol Date: 2007-09-20 Impact factor: 2.953